Tokyo Tape
Sign in
← Astellas Pharma

Annual report

4503.TEDINET S100TNPZ
Period2023-04-01 → 2024-03-31
Filed2024-06-20
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥1.60T2023-04-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥1.52T2022-04-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥1.30T2021-04-01 → 2022-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.25T2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.30T2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥25.5bn2023-04-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥133.0bn2022-04-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥25.0bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥132.4bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥156.9bn2021-04-01 → 2022-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥145.3bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥245.3bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥17.0bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥98.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥124.1bn2021-04-01 → 2022-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥120.6bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥195.4bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥17.0bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥98.7bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥3.57Tat 2024-03-31Cons.Assets IFRS
Total assets¥2.46Tat 2023-03-31Cons.Assets IFRS
Total assets¥2.33Tat 2022-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥2.27Tat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥2.32Tat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥1.97Tat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥948.6bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥1.60Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥1.51Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.46Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥1.60Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.51Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.39Tat 2021-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.29Tat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥335.7bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥376.8bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥316.0bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥326.1bnat 2021-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥318.4bnat 2020-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥172.5bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥327.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥257.4bn2021-04-01 → 2022-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥306.8bn2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥222.0bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥845.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥84.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥62.4bn2021-04-01 → 2022-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥81.9bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥389.8bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow¥614.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥195.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥216.3bn2021-04-01 → 2022-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥229.5bn2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥181.1bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥9.512023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥54.242022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥67.082021-04-01 → 2022-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥64.932020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥104.152019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥9.472023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥54.092022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.052021-04-01 → 2022-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥64.92020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥104.082019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥890.07at 2024-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥839.26at 2023-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥799.26at 2022-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥748.03at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥694.03at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio44.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio61.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.6%at 2022-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio61.0%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio55.7%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE1.1%2023-04-01 → 2024-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE6.7%2022-04-01 → 2023-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE8.7%2021-04-01 → 2022-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE9.0%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE15.3%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees14,754at 2024-03-31Cons.Number of employees
Employees14,484at 2023-03-31Cons.Number of employees
Employees14,522at 2022-03-31dCons.Number of employees
Employees15,455at 2021-03-31dCons.Number of employees
Employees15,883at 2020-03-31dCons.Number of employees
Revenue¥688.4bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥613.6bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥542.6bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥545.6bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥600.6bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥194.0bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥130.6bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥373.3bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥338.2bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥270.5bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥223.4bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥293.2bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥333.1bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥348.1bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥292.2bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥314.2bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥225.1bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥193.1bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥240.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥2.46Tat 2024-03-31StandaloneAssets
Total assets¥1.49Tat 2023-03-31StandaloneAssets
Total assets¥1.39Tat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.35Tat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.33Tat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.28Tat 2024-03-31StandaloneLiabilities
Total liabilities¥466.1bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.18Tat 2024-03-31StandaloneNet assets
Net assets / equity¥1.02Tat 2023-03-31StandaloneNet assets
Net assets / equity¥873.6bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥787.7bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥671.6bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥153.1bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥217.0bnat 2023-03-31StandaloneCash and deposits
EPS (basic)¥162.922023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥172.642022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥121.692021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥103.952020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥128.262019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥162.872023-04-01 → 2024-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥172.572022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥121.632021-04-01 → 2022-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥103.892020-04-01 → 2021-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥128.172019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥702023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥602022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥502021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥422020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥402019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥660at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥568.97at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥477.81at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥424.69at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥361.08at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio48.1%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio68.7%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio62.9%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio58.3%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio50.4%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE26.5%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE33.2%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE27.1%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE26.5%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE39.0%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued1,809,663,000at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,809,663,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,835,852,000at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,861,787,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,861,787,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees4,806at 2024-03-31StandaloneNumber of employees
Employees4,867at 2023-03-31StandaloneNumber of employees
Employees3,943at 2022-03-31dStandaloneNumber of employees
Employees4,647at 2021-03-31dStandaloneNumber of employees
Employees4,560at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceuticalreportable segmentemployeesat 2024-03-3114754 pure
Pharmaceuticalreportable segmentemployeesat 2024-03-314806 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,686
ItemContextValueUnit
Number of employeesPrior4YearInstant_NonConsolidatedMember4560
Number of employeesPrior3YearInstant_NonConsolidatedMember4647
Number of employeesPrior2YearInstant_NonConsolidatedMember3943
Number of employeesPrior1YearInstant_NonConsolidatedMember4867
Number of employeesCurrentYearInstant_NonConsolidatedMember4806
Total shareholder returnPrior4YearInstant_NonConsolidatedMember1.032
Total shareholder returnPrior3YearInstant_NonConsolidatedMember1.076
Total shareholder returnPrior2YearInstant_NonConsolidatedMember1.232
Total shareholder returnPrior1YearInstant_NonConsolidatedMember1.251
Total shareholder returnCurrentYearInstant_NonConsolidatedMember1.149
Total return on share price indexPrior4YearInstant_NonConsolidatedMember0.905
Total return on share price indexPrior3YearInstant_NonConsolidatedMember1.286
Total return on share price indexPrior2YearInstant_NonConsolidatedMember1.312
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.388
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.962
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00920-000PharmaceuticalReportableSegmentMember14754
Number of employeesCurrentYearInstant14754
Number of employeesCurrentYearInstant_NonConsolidatedMember4806
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember42.7
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember16.5
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember11104334JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00920-000PharmaceuticalReportableSegmentMember4806
Number of employeesCurrentYearInstant_NonConsolidatedMember4806
Ratio of female employees in managerial positions metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.163
All employees calculated based on provisions of article714 item2 of ordinance for enforcement of act on childcare leave caregiver leave and other measures for the welfare of workers caring for children or other family members ratio of male employees taking childcare leave metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.931
All employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.736
Regular employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.743
Non regular employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.715
Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metricsCurrentYearInstant_Row1Member86
Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metricsCurrentYearInstant_Row2Member5.9
Research and development expenses research and development activitiesCurrentYearDuration294200000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration35446000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1809663075
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1809663075
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1809663075
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1809663075
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember183
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember67
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember1277
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember988
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember1429
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember271140
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember275084
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember6562712
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember1202678
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember617367
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember7214270

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2024-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass